EU approves Arrowhead's plozasiran for rare triglyceride disorder
Go back to EU approves Arrowhead's plozasiran for rare triglyceride disorder| ARROWHEAD RESEARCH (NASDAQ: ARWR) | Delayed: 86.78 -1.92 (2.16%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $88.70 | 52 Week High | $8.22 | |||
| Open | $88.72 | 52 Week Low | $3.07 | |||
| Day High | $89.15 | P/E | N/A | |||
| Day Low | $86.26 | EPS | $-1.30 | |||
| Volume | 2,479,804 | |||||
